Exhibit 107

Calculation of Filing Fee Tables

Form S-1

(Form Type)

GT Biopharma, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

	Security  Type	Security Class Title	Fee Calculation or Carry Forward Rule	Amount Registered (1)		Proposed Maximum Offering Price Per Unit (2)		Maximum Aggregate Offering Price		Fee Rate		Amount of Registration Fee		Carry Forward  Form Type		Carry Forward  File Number		Carry Forward  Initial effective  date		Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward
Newly Registered Securities
Fees to Be   Paid	Equity	Common Stock, $.0001 par value per share	Rule 457(c)		740,000	$	2.92	$	2,160,800.00		0.00014760	$	318.93
Fees  Previously   Paid	—	—	—		—		—		—				—
Carry Forward Securities
Carry  Forward  Securities	—	—	—		—				—				—		—		—		—		—
	Total Offering Amounts							$	2,160,800.00			$	318.93
	Total Fees Previously Paid												—
	Total Fee Offsets												—
	Net Fee Due											$	318.93

(1) Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder include such indeterminate number of additional securities as may, from time to time, become issuable by reason of stock splits, stock dividends, recapitalizations or other similar transactions.

(2) Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act of 1933, as amended, based on the average of the high and low prices reported by the Nasdaq Capital Market on June 14, 2024.